Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.54B
Market cap12.54B
Price-Earnings ratio
73.20
Price-Earnings ratio73.20
Dividend yield
Dividend yield
Average volume
302.20K
Average volume302.20K
High today
$318.94
High today$318.94
Low today
$317.68
Low today$317.68
Open price
$317.68
Open price$317.68
Volume
344.02K
Volume344.02K
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

As of today, Penumbra(PEN) shares are valued at $318.82. The company's market cap stands at 12.54B, with a P/E ratio of 73.20.

During the trading session on 2026-07-14, Penumbra(PEN) shares reached a daily high of $318.94 and a low of $317.68. At a current price of $318.82, the stock is +0.4% higher than the low and still -0.0% under the high.

Trading volume for Penumbra(PEN) stock has reached 344.02K, versus its average volume of 302.2K.

Over the past 52 weeks, Penumbra(PEN) stock has traded between a high of $362.41 and a low of $221.26.

Over the past 52 weeks, Penumbra(PEN) stock has traded between a high of $362.41 and a low of $221.26.

PEN News

Investing.com 7d
Penumbra initiates study on stroke treatment for distal occlusions - Investing.com

...

Penumbra initiates study on stroke treatment for distal occlusions - Investing.com
TipRanks 7d
Penumbra announces the initiation of its FORWARD study

Penumbra (PEN) announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and ef...

Analyst ratings

92%

of 12 ratings
Buy
8.3%
Hold
91.7%
Sell
0%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.